Complement receptor type 2
| GO Term | Evidence Code | Reference |
|---|---|---|
| T cell mediated immunity | ||
| inflammatory response | ||
| complement activation, alternative pathway | ||
| complement activation, alternative pathway | ||
| complement activation, alternative pathway |
| GO Term | Evidence Code | Reference |
|---|---|---|
| obsolete extracellular space |
|
|
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane |
| GO Term | Evidence Code | Reference |
|---|---|---|
| complement binding | ||
| DNA binding | ||
| complement receptor activity | ||
| complement receptor activity | ||
| transmembrane signaling receptor activity |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 77 |
|
|
||
| 113 |
|
|
||
| 276 |
|
|
||
| 316 |
|
|
||
| 364 |
|
|
||
| 380 |
|
|
||
| 484 |
|
|
||
| 527 |
|
|
||
| 615 |
|
|
||
| 639 |
|
|
| Pathway Name | Organism |
|---|---|
| Regulation of Complement cascade | Mus musculus |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026